Linked e-resources

Details

Intro
Preface
Acknowledgments
Contents
Chapter 1: Introduction
References
Part I: Current Health Risk Assessment of Chemicals
Chapter 2: The Safe Dose in the Utilization of Chemicals
2.1 Dose-Response Curve
2.2 Health Risk Assessment of Rotenone and Simazine
2.2.1 Rotenone
2.2.2 Simazine
2.3 Health Risk Assessment of Dioxin-Induced Malformation of Reproductive Organs
References
Chapter 3: Carcinogens
3.1 Carcinogens
3.2 Health Risk Assessment of Carcinogens
3.2.1 Long-Term Carcinogenicity Studies

3.2.2 Carcinogenicity Studies with Surrogates
3.3 Dose-Response Curve and Carcinogenic Mechanism of Benzo[a]Pyrene
3.3.1 Carcinogenic Mechanism of Benzo[a]Pyrene
3.4 Various Carcinogens and their Dose-Response Curves
3.5 Research on Carcinogens by Prof. Shoji Fukushima
3.6 Dose-Response Curve of TPA (12-O-Tetradecanoylphorbol 13-Acetate)
3.7 How to Interpret the Dose-Response Curve
3.8 Health Risk Assessment of Radiation
3.9 Genome Mutation
3.9.1 Mutation as a Factor in the Evolution
3.9.2 Mutation as a Factor of Carcinogenesis

3.9.3 Establishment of Mutagenicity Study Methods
3.10 Characteristics of Cancer
3.10.1 Carcinogenic Process in Colorectal Cancer
3.11 Ideas Relating to the Health Risk Assessment of Carcinogens
3.12 Concept of the Lifetime Risk of Carcinogenesis
3.12.1 Carcinogenic Risk of Benzo[a]Pyrene
3.12.2 Carcinogenic Risk of Chlordane
3.12.3 Benchmark Dose Method (BMDL: Benchmark Dose Lower Confidence Level)
3.13 Experiment on Cells with a Tumorigenic Probability of 10-6
3.14 The Signature of Cancer Genome Mutation
References
Chapter 4: Endocrine Disruptors

4.1 Dose Response of Endocrine Hormones
4.2 Dose Response of Bisphenol A
4.3 Carcinogenicity Evaluation of Bisphenol A
4.4 Health Risk Assessment of Bisphenol A
4.5 Strict Set Values for EU
References
Chapter 5: Nanomaterials
5.1 Physical Properties of Nanomaterials
5.2 Nanomaterials
5.2.1 Physicochemical Properties of Carbon Nanotubes
5.3 Dose-Response Curve of Nanomaterials
5.4 Carcinogenicity Evaluation of Carbon Nanotube
5.4.1 Health Risk Assessment of MWNT-7
References
Chapter 6: Epigenetic Chemicals
6.1 Epigenetic Chemicals

6.2 The Impact of Arsenic on the Epigenetic Mechanism
References
Chapter 7: Toward the Integrated Health Risk Assessment of Chemicals
7.1 Toxicology, Epidemiology, and Health Risk Assessment
7.2 Predominance of the Epidemiological Data
7.3 Dichloromethane (DCM) and 1,2-Dichloropropane (1,2-DCP)
7.3.1 Recent Cases of Cholangiocarcinoma
References
Part II: New Concepts of Toxicological Mechanisms of Chemicals
Chapter 8: Expanded Toxicological Mechanisms of Chemicals
8.1 A Strategy for New Aspects of Health Risk Assessment
8.2 Three Exposure Routes of Chemicals

Browse Subjects

Show more subjects...

Statistics

from
to
Export